Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 10, 2008HaematologicaOpen Access

Inflammation and oxidant-stress in  -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial

View Full Paper
Ask AI
Bookmark
Share

Authors

PWP. B. WalterEMEric A. MacklinMassachusetts General HospitalJPJohn B. PorterUniversity College Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Walter et al. (2008) studied this question.

synapsesocial.com/papers/6a833e75f41d4f5c6da0f176https://doi.org/10.3324/haematol.11755
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of Iron in Inducing Oxidative Stress in Thalassemia: Can It Be Prevented by Inhibition of Absorption and by Antioxidants?2005 · 90 citations
  2. 2Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation1989 · 146 citations